Key result
Diabetes mellitus in patients undergoing CABG was not associated with increased early mortality (2.2% vs 3.1%; OR 0.44) but was associated with increased long-term mortality (RR 1.87, CI 1.60-2.14).
Why the study?
Does diabetes mellitus increase the risk of morbidity and mortality in patients undergoing coronary artery bypass surgery?
Cohort (n=1,025)
Does diabetes mellitus increase the risk of morbidity and mortality in patients undergoing coronary artery bypass surgery?
Effect estimate: OR 0.44 (95% CI 0.05-3.56)
Absolute Event Rate: 2.2% vs 3.1%
Diabetes mellitus is associated with increased long-term mortality after CABG, but does not significantly increase the risk of early mortality or perioperative complications.
Of 1025 patients (912 men, 113 women) who underwent coronary artery bypass grafting and were followed up for a mean of 7.4 years, 45 (4.4%) had diabetes mellitus. Norwegian population is 1.8-2%). Early mortality was not significantly greater among diabetics than in non-diabetics (2.2 vs. 3.1%, odds ratio--OR-0.44, confidence interval--CI- 0.05-3.56). Diabetic patients had no increased risk of perioperative myocardial infarction (OR = 0.87, CI 0.36-2.10) or of low-output syndrome necessitating intraortic balloon pumping (OR = 0.42, CI 0.55-3.05), and no excess incidence of late non-fatal myocardial infarction (relative risk = 0.69, CI 0.10-1.28) or late chronic heart failure (OR = 2.50, CI 0.5-11.0). Long-term mortality was increased in the diabetic patients (relative risk 1.87, CI 1.60-2.14). Thus diabetes did not entail heightened risk of early mortality, perioperative myocardial infarction or low-output syndrome. Nor was there excess risk of recurrent angina pectoris, late non-fatal myocardial infarction or chronic heart failure among the diabetic patients, but the late mortality risk was increased.
No takes yet. Share an insight, caveat, or question.
Risum et al. (1996) conducted a cohort in Coronary artery bypass grafting (n=1,025). Diabetes mellitus vs. Non-diabetics was evaluated on Early mortality (OR 0.44, 95% CI 0.05-3.56). Diabetes mellitus in patients undergoing CABG was not associated with increased early mortality (2.2% vs 3.1%; OR 0.44) but was associated with increased long-term mortality (RR 1.87, CI 1.60-2.14).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: